+64.1%
CNQ vs GSK
+31.2%
+32.9%
-21.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.3% | -1.9% | +0.6% | -1.4% |
| 7D | +3.0% | -1.8% | +4.8% | +2.9% |
| 30D | +12.8% | -2.2% | +14.9% | +12.6% |
| 3M | +7.0% | -1.8% | +8.8% | +6.9% |
| 6M | +16.5% | -10.6% | +27.1% | +15.5% |
| YTD | +52.0% | +4.4% | +47.6% | +49.8% |
| 1Y | +64.1% | +30.4% | +33.7% | +65.6% |
| All | +64.1% | +31.2% | +32.9% | +65.6% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling